Grindrod Shipping Holdings Ltd. Announces Closing of IVS Bulk Financing and IVS Phoenix Acquisition

Written by Customer Service on September 17, 2021. Posted in Public Companies.

SINGAPORE, Sept. 17, 2021 (GLOBE NEWSWIRE) — Grindrod Shipping Holdings Ltd. (NASDAQ: GRIN) (JSE: GSH) (“Grindrod Shipping” or “Company” or “it” or “we”), a global provider of maritime transportation services predominantly in the drybulk sector, announced the following transactions. On September 15th, 2021, in conjunction with the previously announced acquisition of the remaining 31.14% equity stake in its IVS Bulk joint venture (“IVS Bulk”) and the concurrent redemption of the IVS Bulk preference shares on September 1, 2021, the Company closed the $23 million upsizing of one of its existing IVS Bulk credit facilities to replace the working capital used to fund the transaction. The new debt is on the same terms as the existing facility. On September 16th, 2021, the Company closed the acquisition and concurrent financing...

Protara Therapeutics to Present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit

Written by Customer Service on September 17, 2021. Posted in Public Companies.

NEW YORK, Sept. 17, 2021 (GLOBE NEWSWIRE) — Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases with significant unmet needs, today announced that management will present at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit being held in a virtual setting on Wednesday, September 22, 2021 at 12:25pm ET. A webcast of the presentation can be accessed by visiting the Events and Presentations section of the Company’s website: https://ir.protaratx.com. The webcast will be archived on the Company’s website for 90 days following the presentation. About Protara Therapeutics, Inc. Protara is committed to identifying and advancing transformative therapies for people with cancer and rare diseases with limited treatment options....

Century Therapeutics Announces Its Addition to the Russell 2000® Index

Written by Customer Service on September 17, 2021. Posted in Public Companies.

PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that it will be added to the small-cap Russell 2000® Index as a part of the 3Q21 Russell Indexes IPO additions, effective at US market open on September 20, 2021, according to the preliminary list of IPO additions to the Russell indexes. “Century’s inclusion in the Russell 2000 Index is an important milestone that reflects our continued progress toward advancing our lead therapeutic program, CNTY-101, into the clinic and to patients in need,” said Lalo Flores, Ph.D., Chief Executive Officer of Century Therapeutics. “We are pleased to join the Russell Index and look forward to sharing our potential future...

Passage Bio Announces Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

Written by Customer Service on September 17, 2021. Posted in Public Companies.

PHILADELPHIA, Sept. 17, 2021 (GLOBE NEWSWIRE) — Passage Bio, Inc. (Nasdaq: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced it has granted inducement awards to eight newly hired employees under an inducement plan adopted by its board of directors. Passage Bio granted these employees options to purchase an aggregate of 72,000 shares as a material inducement to their employment (the Inducement Options). The Inducement Options have an exercise price of $11.50 per share, which is equal to the closing price of Passage Bio’s common stock on September 15, 2021, the grant date of the Inducement Options. The Inducement Options were granted in accordance with Nasdaq listing Rule 5635(c)(4). The shares subject to the Inducement Options...

Wintrust Financial Corporation Announces Third Quarter and Year-to-Date 2021 Earnings Release Schedule

Written by Customer Service on September 17, 2021. Posted in Public Companies.

ROSEMONT, Ill., Sept. 17, 2021 (GLOBE NEWSWIRE) — Wintrust Financial Corporation (“Wintrust”) (Nasdaq: WTFC) today announced it will release its third quarter and year-to-date 2021 earnings results after the market closes on Tuesday, October 19, 2021 and host a conference call on Wednesday, October 20, 2021 at 12:00 p.m. (EDT). Individuals interested in participating in the call should dial 877-363-5049 and enter Conference ID #2695417 or a simultaneous audio-only web cast may be accessed via the Company’s web site at http://www.wintrust.com, Investor Relations link. An accompanying slide presentation for those participating in the call or listening via web cast will be available on the Company’s web site at http://www.wintrust.com, Investor Relations link. A replay of the audio-only webcast and an accompanying slide...

Nuwellis, Inc. Announces Closing of $10.0 Million Underwritten Public Offering of Common Stock Including Full Exercise of Over-Allotment Option

Written by Customer Service on September 17, 2021. Posted in Public Companies.

EDEN PRAIRIE, Minn., Sept. 17, 2021 (GLOBE NEWSWIRE) — Nuwellis, Inc. (NASDAQ:NUWE) (the “Company”) announced today the closing of its previously announced underwritten public offering of 4,005,588 shares of its common stock at a price to the public of $2.50 per share, for gross proceeds of approximately $10.0 million, including the full exercise of the underwriters’ over-allotment option to purchase additional shares of the Company’s common stock, prior to deducting underwriting discounts and commissions and offering expenses payable by the Company. Ladenburg Thalmann & Co. Inc. acted as sole book-running manager in connection with the offering. Maxim Group LLC acted as lead manager for the offering. The Company intends to use the net proceeds for the offering for general corporate purposes, including the continued investment...

CIIG Capital Partners II, Inc. Announces Closing of Upsized $287,500,000 Initial Public Offering

Written by Customer Service on September 17, 2021. Posted in Public Companies.

September 17, 2021 | Source: CIIG Capital Partners II, Inc. New York, NY, Sept. 17, 2021 (GLOBE NEWSWIRE) — CIIG Capital Partners II, Inc. (“CIIG II”), a blank check company formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses, announced today that it closed its upsized initial public offering of 28,750,000 units at $10.00 per unit, including 3,750,000 units issued pursuant to an exercise by the underwriters of their over-allotment option. While CIIG II may pursue an initial business combination target in any business or industry, it intends to focus its search on companies in technology, media, telecommunications and sustainability (“TMTS”) industries. CIIG II is led by Executive Chairman, Peter Cuneo,...

LexaGene Adopts Corporate Governance Charters and Policies

Written by Customer Service on September 17, 2021. Posted in Public Companies.

BEVERLY, Mass., Sept. 17, 2021 (GLOBE NEWSWIRE) — LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (“LexaGene” or the “Company”), a commercial molecular diagnostics company selling a point-of-need highly multiplexed in-clinic PCR system with results in approximately two hours, today announced the Company has adopted new corporate governance charters and policies. Dr. Jack Regan, LexaGene’s CEO and Founder stated, “The Board of Directors, along with our leadership team, take good corporate governance seriously. The Board reviewed our existing charters and policies and felt it was time to modernize them. By doing so, we are elevating our effectiveness and moving in a direction where accountability, the ability to manage resources, and improving our performance strengthen strategic business imperatives.” The Board of Directors...

Photo Release — Ingalls Shipbuilding Successfully Completes Acceptance Trials for Frank E. Petersen Jr. (DDG 121)

Written by Customer Service on September 17, 2021. Posted in Public Companies.

PASCAGOULA, Miss., Sept. 17, 2021 (GLOBE NEWSWIRE) — Huntington Ingalls Industries (NYSE: HII) announced today that its Ingalls Shipbuilding division completed the final round of sea trials for Arleigh Burke-class guided missile destroyer Frank E. Petersen Jr. (DDG 121). “The successful completion of acceptance trials is an extremely rewarding accomplishment for Ingalls and for our partners who work closely with us to ensure we achieve this milestone together,” Ingalls Shipbuilding President Kari Wilkinson said. “We are proud of our shipbuilders for working as a team to move DDG 121 one step closer to delivery.” DDG 121 is named for Frank E. Petersen Jr., who was the U.S. Marine Corps’ first African-American aviator and general officer. After entering the Naval Aviation Cadet Program in 1950, Petersen would go on to fly more than...

Freddie Mac Announces Pricing of $403 Million Multifamily Small Balance Loan Securitization

Written by Customer Service on September 17, 2021. Posted in Public Companies.

MCLEAN, Va., Sept. 17, 2021 (GLOBE NEWSWIRE) — Freddie Mac (OTCQB: FMCC) announces the pricing of the SB90 offering, a multifamily mortgage-backed securitization backed by small balance loans underwritten by Freddie Mac and issued by a third-party trust. The company expects to issue approximately $403 million in SB Certificates (SB90 Certificates), which are expected to settle on or about September 24, 2021. Freddie Mac Small Balance Loans generally range from $1 million to $7.5 million and are generally backed by properties with five or more units. This is the ninth SB Certificate transaction in 2021. SB90 Pricing Class Principal/Notional Amount (mm) Weighted Average Life (Years) Spread (bps) Coupon Yield Dollar Price A-5F $108.625 4.01 -1 0.8800% 0.7398% 100.4992 A-7H $121.960 5.41 17 1.2300% 1.1216% 100.4978 A-10F $109.903 7.22 18 1.4100% 1.3277% 100.4922 A-10H $63.421 7.17 31 1.5300% 1.4539% 100.4407 X-1 $403.910 5.80 2,550 0.6573% 26.2721% 5.1029 Details:...

Day: September 17, 2021

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice